Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3217 | IMRX Immuneering Corporation - Class A Common Stock | 5.19 USD | -2.08% | +2.17% | +18.49% | +8.13% | 335.78 M USD | ||
| 3231 | IRD Opus Genetics, Inc. - Common Stock | 3.85 USD | -4.94% | +5.77% | +25.00% | +3.49% | 320.30 M USD | ||
| 3238 | IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.36 USD | -1.26% | -1.26% | 0.00% | +26.88% | 329.30 M USD | ||
| 3243 | YDES YD Bio Limited - Ordinary Shares | 4.71 USD | +0.43% | +59.12% | +113.12% | -41.13% | 333.42 M USD | ||
| 3267 | OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 5.35 USD | -0.19% | +19.42% | +40.79% | +109.80% | 321.56 M USD | ||
| 3276 | VNDA Vanda Pharmaceuticals Inc. - Common Stock | 5.24 USD | -0.76% | -0.57% | +1.16% | -5.24% | 316.82 M USD | ||
| 3322 | NMRA Neumora Therapeutics, Inc. - Common Stock | 1.61 USD | -1.23% | +5.92% | +6.62% | -0.62% | 302.51 M USD | ||
| 3327 | RNAC Cartesian Therapeutics, Inc. - Common Stock | 9.70 USD | -3.39% | +9.48% | +21.40% | +5.90% | 293.48 M USD | ||
| 3340 | AVXL Anavex Life Sciences Corp. - Common Stock | 3.13 USD | -3.40% | -2.19% | +29.88% | -67.09% | 290.06 M USD | ||
| 3350 | ACIU AC Immune SA - Common Stock | 2.97 USD | +2.41% | +18.33% | +32.59% | +39.44% | 302.17 M USD | ||
| 3352 | IVVD Invivyd, Inc. - Common Stock | 0.94 USD | -6.00% | +34.29% | +54.10% | +77.36% | 277.07 M USD | ||
| 3353 | TRDA Entrada Therapeutics, Inc. - Common Stock | 7.12 USD | -5.94% | -4.30% | +19.66% | +2.15% | 277.23 M USD | ||
| 3360 | FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.82 USD | -0.26% | -0.78% | +1.60% | -44.48% | 291.46 M USD | ||
| 3385 | ALXO ALX Oncology Holdings Inc. - Common Stock | 1.97 USD | -3.43% | +1.03% | -2.96% | +61.48% | 272.41 M USD | ||
| 3388 | SRZN Surrozen, Inc. - Common Stock | 23.60 USD | -1.63% | -2.96% | +16.03% | +105.40% | 277.38 M USD | ||
| 3389 | TTRX Turn Therapeutics Inc. - Common Stock | 9.30 USD | -1.69% | -3.23% | +8.27% | -7.00% | 277.03 M USD | ||
| 3396 | ELDN Eledon Pharmaceuticals, Inc. - Common Stock | 3.30 USD | -4.35% | -10.33% | -10.33% | +25.00% | 268.16 M USD | ||
| 3399 | FATE Fate Therapeutics, Inc. - Common Stock | 2.25 USD | -3.43% | -12.45% | -9.64% | +92.31% | 269.60 M USD | ||
| 3416 | LCTX Lineage Cell Therapeutics, Inc. Common Stock | 1.08 USD | -0.92% | 0.00% | +2.86% | -37.21% | 273.14 M USD | ||
| 3419 | ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 3.86 USD | +0.78% | +8.43% | -11.47% | +94.95% | 276.65 M USD |
Notícias Biotechnology Stocks
Dinamarca - Ações fecharam o pregão em alta e o Índice OMX Copenhagen 20 avançou 0,41%
Deutsche Bank rebaixa argenx para neutro após valorização expressiva
Por que as ações da Monte Rosa Therapeutics estão caindo hoje?
Ações da Biomea Fusion disparam com conclusão de inscrições em estudo sobre diabetes
Ações da Monte Rosa caem com início de estudo de fase 2 contra câncer de próstata
Ação da Crinetics Pharmaceuticals atinge máxima histórica de US$ 84,80
H.C. Wainwright reitera recomendação para Biomea Fusion após conclusão de recrutamento em ensaio clínico
Gainers Biotechnology Stocks
SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |